SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova informs about completion of voluntary prepayment

25 Jun 2024 Evaluate

In continuation to Company’s earlier communication dated June 14, 2024 regarding voluntary prepayment of USD 75 million term loan, equivalent to Rs. 626 Cr, Jubilant Pharmova has confirmed that Jubilant Pharma Holdings Inc., USA (‘JPHI’), a wholly owned subsidiary of Jubilant Pharma (‘JPL’), and a wholly owned subsidiary of the Company has completed the voluntary prepayment of above-mentioned term loan on June 24, 2024. The above-mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×